Last reviewed 2026-04-20 · How we verify

Morphine s.c.

Sankt Lukas Hospice · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Morphine s.c.
Sponsor	Sankt Lukas Hospice
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. (PHASE3)
Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China (PHASE4)
Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab (PHASE4)
Subcutaneous Versus Intravenous Morphine When Switching From Oral to Parenteral Route in Palliative Cancer Patients (PHASE3)
CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma (PHASE2)
Effects of Dexmedetomidine on Cognitive Outcome and Brain Injury Markers (NA)
Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab (PHASE2)
Spinal Morphine in Robotic Assisted Radical Prostatectomy (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results